Category: The Pulse

Sessions Says Obama-Era Marijuana Policy Will Remain in Effect

After a crusade to try and repeal Obama-era policies protecting states’ marijuana laws, Attorney General Jeff Sessions has finally come to announce that they “are bound by” current policies, which will remain in effect for the time being. “Our policy is the same, really, fundamentally as the Holder-Lynch policy, which is that the federal law remains in effect and a state can legalize marijuana for its law enforcement purposes but it still remains illegal with regard to federal purposes,” Forbes reported Sessions as saying, referring to previous attorneys general and their policy. This announcement (of sorts) comes after months of...

Read More

11-17-2017 Video News – The Marijuana Time Show

Cannabis News – Being Green in a Green Industry | Ep. 10 | 11-17-2017  Joe Klare discusses a green company doing things right in the cannabis industry, the real story behind the “first marijuana overdose death” and new emergency regulations for adult use cannabis in California. 11-17-2017 – Ep. 10 | Marijuana Times Show https://www.marijuanatimes.org/being-green-in-the-marijuana-industry-hisierra-dispensary-bags/ https://www.washingtonpost.com/news/to-your-health/wp/2017/11/17/the-truth-behind-the-first-marijuana-overdose-death/ http://www.pressdemocrat.com/news/7649991-181/california-marijuana-rules-mark-step Sponsor: http://naturecidecannabis.com/ TroyFlowers Author description...

Read More

Introducing The World’s First 100% Automated Grow Box

At one point or another, most cannabis users have sat around with their friends and discussed what they imagined the future would be like, especially what a world of legal cannabis would look like. Now that legal cannabis is a reality in so many states, that future is beginning to be realized. Full disclosure: no matter how legal cannabis becomes, I’ll never be able to grow it. I can do some things well, but keeping plant life alive is not one of them. But that future I mentioned has come to help me as technology and engineering have combined...

Read More

11-16-2017 Video News – The Marijuana Times Show

Joe Klare discusses the latest sales numbers out of Colorado, .NBA star Karl Anthony-Towns on medical marijuana and a possible delay in legalization in New Jersey. 11-16-2017 – Ep. 9 | Marijuana Times Show https://www.marijuanatimes.org/marijuana-shops-in-colorado-take-in-another-136-million-in-september/ https://www.cbssports.com/nba/news/karl-anthony-towns-nba-should-remove-marijuana-from-banned-substances-list/ http://www.nj.com/politics/index.ssf/2017/11/a_snag_for_legal_pot_in_nj_new_assembly_speaker_wo.html Sponsor: http://naturecidecannabis.com/ TroyFlowers Author description...

Read More

InMed to Present at Cannabis-Based Science & Medicine Conference

SHARE THIS POST Vancouver, BC – November 16, 2017 – InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE:IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today it will present at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference on Thursday, November 30th and Friday, December 1st, 2017 in Denver, CO. Dr. Sazzad Hossain, InMed’s Chief Scientific Officer, will be presenting a lecture entitled “Epidermolysis to Glaucoma – Identifying Pathology Candidates for Cannabis-Based Treatments.” This presentation will highlight InMed’s internal process of identifying disease targets for treatment with therapeutic cannabinoid compounds, developing tissue-specific delivery formulations, and innovative approaches to addressing regulatory challenges with cannabinoid-based therapies. More information on this conference, organized by CBI – a division of UBM, is available at: http://www.cbinet.com/conference/pc17091 About InMed InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics platform, its biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the Company. For more information, visit www.inmedpharma.com. Contact: InMed Pharmaceuticals Inc. Chris Bogart Investor Relations T: 604.669.7207 E: chris@inmedpharma.com TroyFlowers Author description...

Read More

Marijuana Shops in Colorado Take in Another $136 Million in September

According to new estimates from The Cannabist, recreational and medical marijuana stores in Colorado sold over $136 million in products in September of 2017. Since actual sales numbers aren’t available in Colorado, The Cannabist gets their estimates by extrapolating sales data from tax revenue data. During the first three-quarters of the year cannabis shops in Colorado have exceed $1.1 billion in sales, up 19% from the same period last year. Earlier this year, however, the annual rate of growth was at about 36%, leading some to speculate on whether a plateau in marijuana sales is coming in Colorado. The...

Read More